“I have a very dense filter when it comes to ideas, because most of them are either features or their products, but they're not company ideas.”
Cyriac Roeding · Business Of Biotech · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
Play from 13:10
13:10
Audio streams from the publisher’s own feed. Verbatim does not host or copy it.
What was described
Evaluated over 200 potential biotech ideas using a dense filter to separate features/products from true company ideas, aiming only for “outstanding” concepts.
Said nearby on the same subject
“A U.S.-led sovereign wealth fund for preclinical and early stage biotechs ... I think it's an interesting idea, but ... the things that I described are probably more top of mind”
“We really start the development cycle out a year to a year and a half early. We bring in our suppliers ... start with concepts ... ideas turn into drawings, CADs, molds, sampling.”
“We came up with an idea for this particular industrial company and they go, no… could that work with this other company? … we call that company and say…”